Description: The forefront of developing and bringing to market a range of innovative imaging, therapeutic and diagnostic products based on our proprietary calcitonin receptor antibody technology CalRexin®.
what we do with CalRexin™
Apop Biosciences offers proprietary antibody : fluorophore conjugates to scientists for innovative research & understanding of new events in programmed cell death in live cells.
Apop Biosciences is developing CalRexin™ into a powerful delivery vehicle for drug conjugates to treat refractory tumours, and unmet medical need.